These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 15543179)

  • 21. Unpredictability of glaucoma progression.
    Susanna R
    Curr Med Res Opin; 2009 Sep; 25(9):2167-77. PubMed ID: 19601708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic antihypertensive medication and incident open-angle glaucoma.
    Müskens RP; de Voogd S; Wolfs RC; Witteman JC; Hofman A; de Jong PT; Stricker BH; Jansonius NM
    Ophthalmology; 2007 Dec; 114(12):2221-6. PubMed ID: 17568677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma.
    Crandall J; Matragoon S; Khalifa YM; Borlongan C; Tsai NT; Caldwell RB; Liou GI
    Ophthalmic Res; 2007; 39(2):69-75. PubMed ID: 17284931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nimesulide oral administration increases the intraocular pressure-lowering effect of latanoprost in patients with primary open-angle glaucoma.
    Costagliola C; Parmeggiani F; Caccavale A; Sebastiani A
    Am J Ophthalmol; 2006 Feb; 141(2):379-81. PubMed ID: 16458700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The diagnosis and treatment of glaucoma].
    Vesti E
    Duodecim; 1995; 111(11):1059-62. PubMed ID: 9081845
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of localized retinal nerve fiber layer defects between a low-teen intraocular pressure group and a high-teen intraocular pressure group in normal-tension glaucoma patients.
    Kim DM; Seo JH; Kim SH; Hwang SS
    J Glaucoma; 2007 May; 16(3):293-6. PubMed ID: 17438422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glaucoma care and clinical profile in Priest Hospital, Thailand.
    Sothornwit N; Jenchitr W; Pongprayoon C
    J Med Assoc Thai; 2008; 91 Suppl 1():S111-8. PubMed ID: 18672602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lifetime visual disability in open-angle glaucoma and ocular hypertension.
    Forsman E; Kivelä T; Vesti E
    J Glaucoma; 2007 May; 16(3):313-9. PubMed ID: 17438426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comments on: Current concepts in the pathogenesis and management of exfoliation syndrome and exfoliative glaucoma.
    Brooks AM
    Compr Ophthalmol Update; 2006; 7(3):143-4. PubMed ID: 16882402
    [No Abstract]   [Full Text] [Related]  

  • 30. Intercurrent factors associated with the development of open-angle glaucoma in the European glaucoma prevention study.
    Miglior S; Torri V; Zeyen T; Pfeiffer N; Vaz JC; Adamsons I;
    Am J Ophthalmol; 2007 Aug; 144(2):266-275. PubMed ID: 17543874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Light at the end of the tunnel? Advances in the understanding and treatment of glaucoma and inherited retinal degeneration.
    Ofri R; Narfström K
    Vet J; 2007 Jul; 174(1):10-22. PubMed ID: 17307370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective inner retinal dysfunction precedes ganglion cell loss in a mouse glaucoma model.
    Holcombe DJ; Lengefeld N; Gole GA; Barnett NL
    Br J Ophthalmol; 2008 May; 92(5):683-8. PubMed ID: 18296504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retinal nerve fiber layer images captured by GDx-VCC in early diagnosis of glaucoma.
    Zheng W; Baohua C; Qun C; Zhi Q; Hong D
    Ophthalmologica; 2008; 222(1):17-20. PubMed ID: 18097175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ocular hypotensive medications for the treatment of glaucoma.
    Lee DA
    Ophthalmol Clin North Am; 2005 Dec; 18(4):529-38. PubMed ID: 16314217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Status and perspectives of neuroprotective therapies in glaucoma: the European Glaucoma Society White Paper.
    Tamm ER; Schmetterer L; Grehn F
    Cell Tissue Res; 2013 Aug; 353(2):347-54. PubMed ID: 23712457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Glaucoma].
    Bol P
    Ned Tijdschr Tandheelkd; 2003 Jul; 110(7):298-9. PubMed ID: 12891893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The European Glaucoma Prevention Study and the Ocular Hypertension Treatment Study: why do two studies have different results?
    Parrish RK
    Curr Opin Ophthalmol; 2006 Apr; 17(2):138-41. PubMed ID: 16552248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tendencies in the etiopathogenesis of glaucoma--present and future].
    Călugăru D; Călugăru M
    Oftalmologia; 2008; 52(3):10-22. PubMed ID: 19149112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment concept in glaucoma].
    Orgül S
    Praxis (Bern 1994); 2000 Jan; 89(4):151-3. PubMed ID: 10686808
    [No Abstract]   [Full Text] [Related]  

  • 40. [Investigation of the biomechanical properties of the cornea in patients with normotensive and primary open-angle glaucoma].
    Avetisov SE; Bubnova IA; Antonov AA
    Vestn Oftalmol; 2008; 124(5):14-6. PubMed ID: 19062550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.